NuvOx Therapeutics (NUOX US)

NuvOx Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops innovative oxygen therapeutic solutions for diseases where hypoxia plays a critical role. Its product candidate, NanO2, is administered intravenously to deliver oxygen to tissues, with clinical research focused on acute ischemic stroke, glioblastoma multiforme (GBM), and acute respiratory distress syndrome (ARDS).